New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ARP;ZTS;OII;NCS;NILE;SSH;PTEN;NOV;HP;SFLY;OIS;NBR;EW;SPN;PDS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 14, 2015
12:54 EDTSFLYShutterfly says open to considering transactions that provide 'compelling' value
Subscribe for More Information
10:00 EDTHPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTNCS, SPNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:49 EDTHPHelmerich & Payne downgraded to Equal Weight at Stephens
As previously reported, Stephens downgraded Helmerich & Payne to Equal Weight from Overweight citing the firm's outlook for reduced U.S. onshore spending. The firm said it remain convicted in H&P as a core holding, but that its "hard to get excited" about shares at these levels. Stephens lowered its price target on Helmerich & Payne to $74 from $79.
07:53 EDTNCSNCI Building upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
07:27 EDTHPHelmerich & Payne downgraded to Equal Weight from Overweight at Stephens
05:27 EDTSPNSuperior Energy upgraded to Outperform from Perform at Oppenheimer
Subscribe for More Information
May 13, 2015
18:52 EDTSFLYShutterfly urges shareholders to vote for company's director nominees
Subscribe for More Information
11:35 EDTZTSPhibro deserves multiple more in line with Zoetis, says Cantor
Subscribe for More Information
10:01 EDTNBROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:19 EDTNBRNabors Industries downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
May 12, 2015
10:01 EDTEWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:48 EDTEWEdwards Lifesciences upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Edwards Lifesciences to Overweight following the 15% selloff since mid-March. The firm says its confidence in the conversion of the surgical valve replacement market to transcatheter replacement increased significantly at this year's ACC. It adds that its recent field work indicates the TAVR market has accelerated post-ACC. JPMorgan raised its price target for shares to $155 from $147.
06:35 EDTEWEdwards Lifesciences upgraded to Overweight from Neutral at JPMorgan
May 11, 2015
14:11 EDTSFLYMarathon files proxy materials seeking election to Shutterfly board
Subscribe for More Information
09:59 EDTNOV, PTENOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:24 EDTSFLYBaird sees risk of pullback in Yelp with no deal
Baird analyst Colin Sebastian tells investors this morning that shares of Yelp are at risk of a pullback if a takeover is not consummated "within the relatively near future." Sebastian, while stating Yelp's content and review database could make an attractive acquisition candidate for a "number of platform companies," writes that the risk/reward is "roughly balanced" following last week's rally amid reports of a potential buyout. The analyst cautions that a sales process, as the Wall Street Journal reported Yelp is undertaking, does not guarantee a transaction, as Shutterfly (SFLY) recently showed. With a deal not consummating in the near term, Sebastian sees "increasing risks" in owning Yelp shares above the $50 level. The stock closed Friday at $49.93. Sebastian has a Neutral rating on Yelp with a $46 price target.
08:21 EDTNOV, NBRMitsubishi UFJ to hold a tour
Energy Tour travels throughout Houston and San Antonio, Texas to meet with various energy companies on May 11.
06:14 EDTPTENPatterson-UTI downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Patterson-UTI to Neutral citing the recent rally in shares and its belief onshore focused service providers are most at-risk of profit-taking. The firm keeps a $22 price target for the name.
06:12 EDTNOVNational Oilwell downgraded to Sell from Neutral at Citigroup
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use